|
CDC27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62414526272414E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.80104886139088E-13 |
| Normal-vs-Stage2 |
5.47599999789483E-08 |
| Normal-vs-Stage3 |
2.54241072639161E-14 |
| Normal-vs-Stage4 |
1.62703184258817E-12 |
| Stage1-vs-Stage2 |
9.288200E-01 |
| Stage1-vs-Stage3 |
1.507210E-01 |
| Stage1-vs-Stage4 |
2.602300E-04 |
| Stage2-vs-Stage3 |
3.826400E-01 |
| Stage2-vs-Stage4 |
1.970150E-02 |
| Stage3-vs-Stage4 |
3.597700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
6.64959999951975E-07 |
| Normal-vs-Asian |
8.84670003920007E-10 |
| Caucasian-vs-AfricanAmerican |
9.941200E-01 |
| Caucasian-vs-Asian |
9.836000E-01 |
| AfricanAmerican-vs-Asian |
9.816000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11521902823597E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
6.735000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.77888823063677E-12 |
| Normal-vs-Age(41-60Yrs) |
4.03521660530259E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62914126633495E-12 |
| Normal-vs-Age(81-100Yrs) |
1.429820E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.965200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.998200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.274200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.065220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.882600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.594200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.681700E-02 |
| Classical-VS-Follicular |
4.228200E-01 |
| Classical-VS-Other |
6.103700E-02 |
| Classical-VS-Normal |
1.62858615482264E-12 |
| Tall-VS-Follicular |
2.837600E-01 |
| Tall-VS-Other |
2.517400E-01 |
| Tall-VS-Normal |
2.8986035793821E-11 |
| Follicular-VS-Other |
6.960000E-02 |
| Follicular-VS-Normal |
4.01760003043705E-09 |
| Other-VS-Normal |
3.9399000000051E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00697228333502E-13 |
| Normal-vs-N1 |
3.56814577884279E-12 |
| N0-vs-N1 |
2.134800E-01 |
|
|
